Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 19, 2022

SELL
$300.63 - $371.35 $3.19 Million - $3.94 Million
-10,619 Closed
0 $0
Q3 2021

Nov 03, 2021

BUY
$310.19 - $376.2 $310 - $376
1 Added 0.01%
10,619 $3.46 Million
Q2 2021

Jul 28, 2021

BUY
$262.71 - $351.17 $43,609 - $58,294
166 Added 1.59%
10,618 $3.31 Million
Q1 2021

May 10, 2021

SELL
$285.92 - $355.13 $5,718 - $7,102
-20 Reduced 0.19%
10,452 $3.33 Million
Q4 2020

Feb 03, 2021

SELL
$251.88 - $324.2 $25,691 - $33,068
-102 Reduced 0.96%
10,472 $3.4 Million
Q3 2020

Nov 05, 2020

SELL
$255.22 - $317.0 $619,674 - $769,676
-2,428 Reduced 18.67%
10,574 $2.93 Million
Q2 2020

Jul 13, 2020

BUY
$141.4 - $257.09 $1.84 Million - $3.34 Million
13,002 New
13,002 $3.14 Million

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track West Coast Financial LLC Portfolio

Follow West Coast Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of West Coast Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on West Coast Financial LLC with notifications on news.